B
Catalyst Pharmaceuticals, Inc. CPRX
$21.02 $0.150.72%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income 60.53% 242.65% 8.03% -21.28% 36.80%
Total Depreciation and Amortization 3.45% 10.31% 10.09% 42.88% 1,386.67%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -74.15% -109.77% 4,141.94% 402.04% 22.39%
Change in Net Operating Assets -41.90% 832.98% 155.06% 66.31% -28.58%
Cash from Operations 27.37% 61.48% 108.54% 164.50% 38.85%
Capital Expenditure 99.76% -304.69% -- 99.88% --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing 99.77% 99.72% -- 99.88% --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 763.49% 1,776.42% 229.17% 11,122.20% -78.35%
Repurchase of Common Stock -2.43% -- 100.00% 57.23% -115.71%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -20.11% 3.74% -12.20% -97.05% -22.63%
Cash from Financing 766.62% 41.01% 640.65% 94,563.76% -129.52%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 351.38% 215.26% 113.76% 215.07% -60.63%
Weiss Ratings